Search research articles
Contact Us
Filters
Showing results (21-30 of 95) with videos related to
Page
of 10
Sort By:
Journal of the National Cancer Institute
|
February 8, 2022
Identification of Mitochondrial DNA Variants Associated With Risk of Neuroblastoma
Xiao Chang, Yichuan Liu, Joseph Glessner, et al.
Pediatric Blood & Cancer
|
June 13, 2024
Advancing childhood cancer research through young investigator and advocate collaboration
Amber K Weiner, Antonia Palmer, Melanie Frost Moll, et al.
Bioinformatics (Oxford, England)
|
February 11, 2025
ImmunoTar-integrative prioritization of cell surface targets for cancer immunotherapy
Rawan Shraim, Brian Mooney, Karina L Conkrite, et al.
Genes, Chromosomes & Cancer
|
July 25, 2007
Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression
Yael P Mosse, Sharon J Diskin, Nora Wasserman, et al.
Genome Research
|
August 11, 2006
STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments
Sharon J Diskin, Thomas Eck, Joel Greshock, et al.
Biorxiv : the Preprint Server for Biology
|
December 18, 2023
Advancing childhood cancer research through young investigator and advocate collaboration
Amber K Weiner, Antonia Palmer, Melanie Frost Moll, et al.
Molecular Cancer Therapeutics
|
November 7, 2025
Defining the functional role and potential as an immunotherapeutic target of ALCAM in neuroblastoma
Jarrett Lindsay, Jonathan Gaither, David Groff, et al.
Journal of the National Cancer Institute
|
March 18, 2014
Rare variants in TP53 and susceptibility to neuroblastoma
Sharon J Diskin, Mario Capasso, Maura Diamond, et al.
Journal of the National Cancer Institute
|
December 18, 2012
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival
Eric R Gamazon, Navin Pinto, Anuar Konkashbaev, et al.
Carcinogenesis
|
December 11, 2012
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility
Mario Capasso, Sharon J Diskin, Francesca Totaro, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 95) with videos related to
Sort By:
Page
of 10
Journal of the National Cancer Institute
|
February 8, 2022
Identification of Mitochondrial DNA Variants Associated With Risk of Neuroblastoma
Xiao Chang, Yichuan Liu, Joseph Glessner, et al.
Pediatric Blood & Cancer
|
June 13, 2024
Advancing childhood cancer research through young investigator and advocate collaboration
Amber K Weiner, Antonia Palmer, Melanie Frost Moll, et al.
Bioinformatics (Oxford, England)
|
February 11, 2025
ImmunoTar-integrative prioritization of cell surface targets for cancer immunotherapy
Rawan Shraim, Brian Mooney, Karina L Conkrite, et al.
Genes, Chromosomes & Cancer
|
July 25, 2007
Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression
Yael P Mosse, Sharon J Diskin, Nora Wasserman, et al.
Genome Research
|
August 11, 2006
STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments
Sharon J Diskin, Thomas Eck, Joel Greshock, et al.
Biorxiv : the Preprint Server for Biology
|
December 18, 2023
Advancing childhood cancer research through young investigator and advocate collaboration
Amber K Weiner, Antonia Palmer, Melanie Frost Moll, et al.
Molecular Cancer Therapeutics
|
November 7, 2025
Defining the functional role and potential as an immunotherapeutic target of ALCAM in neuroblastoma
Jarrett Lindsay, Jonathan Gaither, David Groff, et al.
Journal of the National Cancer Institute
|
March 18, 2014
Rare variants in TP53 and susceptibility to neuroblastoma
Sharon J Diskin, Mario Capasso, Maura Diamond, et al.
Journal of the National Cancer Institute
|
December 18, 2012
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival
Eric R Gamazon, Navin Pinto, Anuar Konkashbaev, et al.
Carcinogenesis
|
December 11, 2012
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility
Mario Capasso, Sharon J Diskin, Francesca Totaro, et al.
Page
of 10